Notch Therapeutics
Liz is the Director of Manufacturing at Notch Therapeutics where she leads process development and external GMP manufacturing activities. Her experience is in the areas of pre-clinical and early clinical process development, optimization, and scale up/out of cell and gene therapies, technology transfer, and CMC support. Prior to Notch, Liz worked as a process development manager at CCRM, where she oversaw CCRM’s immunotherapy platform, and managed process development teams executing client-based development projects and internal process and product development. Liz has a PhD in Chemical and Biomedical Engineering from the University of Toronto, and holds an Professional Engineers Ontario (P.Eng) designation.
This person is not in any offices
Notch Therapeutics
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.